Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Bondue (Brussels, Belgium), A. Castiaux (Brussels, Belgium), G. Van Simaeys (Brussels, Belgium), C. Mathey (Brussels, Belgium), F. Sherer (Gosselies, Belgium), D. Egrise (Brussels, Belgium), S. Lacroix (Brussels, Belgium), F. Huaux (Brussels, Belgium), G. Doumont (Gosselies, Belgium), S. Goldman (Brussels, Belgium). Absence of early metabolic response assessed by 18F-FDG PET-CT after initiation of antifibrotic drugs in IPF patients.. 2918

Member's Comments

No comment yet.

Related content which might interest you: Changes in pulmonary 18F-FDG SUVmax reflect treatment response in patients with diffuse parenchymal lung disease; a PET/CT proof of concept study Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 FDG-PET is superior to conventional CT in predicting histologic responses after induction therapy for locally advanced NSCLC Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Value of 18F-FDG PET/CT for predicting postoperative acute exacerbation in idiopathic pulmonary fibrosis Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 18F-FDG PET scans demonstrate strong correlation between spleen metabolism and serum IL-2R levels in patients with untreated sarcoidosis under surveillance Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 Late Breaking Abstract - A PET imaging study to confirm target engagement in the lungs of patients with IPF following a single dose of a novel inhaled avß6 integrin inhibitor Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Correlation of response to antifibrotic treatment with adverse events to antifibrotic drugs in IPF patients from the real-world EMPIRE registry Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Assessment of blood biomarkers in patients with IPF under antifibrotic therapy Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 The role of 18-FDG PET/CT in lung sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 A rejuvenation effect of the antifibrotic therapy correlates with lung function improvement in IPF patients Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma Source: Eur Respir J 2003; 21: 567-573 Year: 2003 The role of computed tomography in differential diagnosis of pulmonary TB in patients with chronic renal failure in the terminal stage. Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018 FDG-PET/CT for monitoring the response to treatment in thoracic and pancreatic sarcoidosis Source: Annual Congress 2009 - Old and new: technique and pathology Year: 2009 Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? Source: Eur Respir J 2011; 37: 162-168 Year: 2011 Longitudinal high-resolution computed tomography (HRCT) assessment and disease progression in patients with Idiopathic Pulmonary Fibrosis (IPF) on antifibrotic therapy Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Does positron emission tomography (PET/CT) have a role to play in the management of patients presenting with pleural changes suggestive of malignancy Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools Year: 2009 Strong correlation between 18F-FDG PET positive bone involvement and increased IL-2R levels in patients with untreated sarcoidosis under surveillance (Preliminary results) Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 18F-fluorodeoxyglucose (18F-FDG) PET/CT assessment of aortic inflammation and calcification in COPD Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Tolerance and efficacy of antifibrotic treatments in IPF patients carriying telomere related gene mutations Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019